Trump Bought Stock in Drugmaker as His Government Boosted Its Obesity Drugs By Darius Tahir May 18, 2026

https://kffhealthnews.org/health-industry/trump-stock-trades-eli-lilly-glp-1-weight-loss-drugs-invest-ethics-disclosures/?utm_campaign=KHN%3A%20First%20Edition&utm_medium=email&_hsenc=p2ANqtz-9cspy62PUrJe7AMgE6EcFrcBmiLdNfVnNS-pqOYybTZxgjOLORFcFWHDcdr2VDuZBQdzHjQINHVsEKnZy8xk4vdcPyCQ&_hsmi=419243754&utm_content=419243754&utm_source=hs_email KFF Health News: Trump Bought Stock In Drugmaker As His Government Boosted Its Obesity Drugs President Donald Trump earlier this year bought as much as $680,000 in stock of Eli Lilly, the maker of blockbuster obesity drugs, as the agencies he oversees undertook an agenda that largely benefited the company. On May 14, the federal government released ethics disclosures revealing a list of stock and bond trades made on Trump’s behalf from January to March of this year. They included extensive trades across the economy, including investments in tech giants such as Microsoft and Nvidia, aerospace firms such as Boeing, and household-name companies such as Target and Chipotle. (Tahir, 5/18)